ES2110101T3 - Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa. - Google Patents

Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa.

Info

Publication number
ES2110101T3
ES2110101T3 ES93915230T ES93915230T ES2110101T3 ES 2110101 T3 ES2110101 T3 ES 2110101T3 ES 93915230 T ES93915230 T ES 93915230T ES 93915230 T ES93915230 T ES 93915230T ES 2110101 T3 ES2110101 T3 ES 2110101T3
Authority
ES
Spain
Prior art keywords
alkyl
aryl
halosubstituted
alkoxy
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93915230T
Other languages
English (en)
Inventor
Takafumi Ikeda
Rodney W Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2110101T3 publication Critical patent/ES2110101T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

CIERTOS NUEVOS DERIVADOS DEL INDOL TIENEN LA HABILIDAD DE INHIBIR LA ENZIMA DE 5-LIPOXIGENASA Y TIENEN LA FORMULA (I) EN DONDE R1 ES ALQUILO C1-C4 O -NR2R3; R2 Y R3 SON CADA UNO INDEPENDIENTEMENTE, HIDROGENO O ALQUILO C1-C4; R4 ES CICLOALQUILO C3-C6, CICLOALQUILALQUILO C4-C7, ALQUILO C2-C4 ARILOXI, ALQUILO C2-C4 ARILTIO, ALQUILO C2-C4 ARILAMINO, ALQUILO C2-C4 ARILSULFINILO, ARILO, ALQUILO C1-C6 ARILO, ALQUILO C1-C6 ARILOXIARILO O ALQUILO C1-C6 ARILTIOARILO, Y LOS GRUPOS ARILO EN DICHO ARILOXIALQUILO, ARILTIOALQUILO, ALRILAMINOALQUILO, ARILSULFINILALQUILO, ARILO, ARILALQUILO, ARILOXIARILALQUILO Y ARILTIOARILALQUILO PODRIAN SER SUSTITUIDOS HASTA EN NUMERO MAXIMO DE SUSTITUYENTES Y LOS SUSTITUYENTES CADA UNO INDEPENDIENTEMENTE, SON SELECCIONADOS DEL GRUPO QUE CONSISTE EN HALO, CIANO, ALQUILO C1-C5, ALQUENILO C2-C6, ALCOXI C1-C5, ALQUENILOXI C2-C6, ALCOXIALQUILO C2-C6, ALQUILO C1-C4 HALOSUSTITUIDO, ALCOXI C1-C4 HALOSUSTITUIDO, ALCOXICARBONILO C2-C5, AMINOCARBONILO Y ALQUILTIO C1-C4; A ES ALQUILENO C1-C6, ALQUENILENO C3-C6 O -O-(CH2)M-; Y ES INDEPENDIENTEMENTE, HALOGENO, ALQUILO C1-C6 HALOSUSTITUIDO, ALQUILO C1-C6, ALQUENILO C2-C6, ALCOXI C1-C6 O ALQUENILOXI C3-C8; M ES 2, 3 O 4; N ES 0, 1, 2 O 3; Y SIEMPRE QUE EL SUSTITUYENTE Y, SI ESTA PRESENTE, Y EL GRUPO A ENLAZANTE ESTEN UNIDOS AL ANILLO AROMATICO. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ALIVIACION DE ENFERMEDADES INFLAMATORIAS, CONDICIONES ALERGICAS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS Y COMO INGREDIENTE ACTIVO EN COMPOSICIONES FARMACEUTICAS PARA TRATAR TALES CONDICIONES.
ES93915230T 1992-07-23 1993-06-10 Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa. Expired - Lifetime ES2110101T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4197242A JP2661841B2 (ja) 1992-07-23 1992-07-23 インドリン誘導体

Publications (1)

Publication Number Publication Date
ES2110101T3 true ES2110101T3 (es) 1998-02-01

Family

ID=16371216

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93915230T Expired - Lifetime ES2110101T3 (es) 1992-07-23 1993-06-10 Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa.

Country Status (24)

Country Link
EP (1) EP0651743B1 (es)
JP (1) JP2661841B2 (es)
KR (1) KR950702533A (es)
CN (1) CN1085894A (es)
AT (1) ATE161250T1 (es)
AU (1) AU675654B2 (es)
BR (1) BR9306762A (es)
CA (1) CA2140344C (es)
CZ (1) CZ15995A3 (es)
DE (1) DE69315841T2 (es)
DK (1) DK0651743T3 (es)
ES (1) ES2110101T3 (es)
FI (1) FI104068B1 (es)
GR (1) GR3025809T3 (es)
HU (1) HUT70182A (es)
IL (1) IL106359A0 (es)
MX (1) MX9304441A (es)
NZ (1) NZ253881A (es)
PL (1) PL307229A1 (es)
SK (1) SK8695A3 (es)
TW (1) TW227556B (es)
WO (1) WO1994002459A1 (es)
YU (1) YU50893A (es)
ZA (1) ZA935304B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8870191A (en) * 1990-10-02 1992-04-28 Stat-Tech International Corporation Electric charge discharge and dissipation device
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
US5952322A (en) * 1996-12-05 1999-09-14 Pfizer Inc. Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
EP1101492A4 (en) * 1998-07-17 2002-09-25 Daiichi Fine Chem Co Ltd MEDICINE AGAINST ALLERGIC DISEASES
EP1283199A4 (en) * 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd MELANIN CONCENTRATION HORMONE ANTAGONIST
UA95084C2 (en) * 2005-11-04 2011-07-11 Амира Фармасутикалз, Инк. 5-lipoxygenase-activating protein (flap) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279263B1 (en) * 1987-02-10 1993-08-04 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
IE903206A1 (en) * 1989-09-07 1991-03-13 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터
US5132319A (en) * 1991-03-28 1992-07-21 Merck Frosst Canada, Inc. 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
NZ253881A (en) 1996-01-26
PL307229A1 (en) 1995-05-15
BR9306762A (pt) 1998-12-08
ATE161250T1 (de) 1998-01-15
FI933307A (fi) 1994-01-24
HU9302126D0 (en) 1993-10-28
HUT70182A (en) 1995-09-28
EP0651743A1 (en) 1995-05-10
FI104068B (fi) 1999-11-15
YU50893A (sh) 1996-07-24
KR950702533A (ko) 1995-07-29
DK0651743T3 (da) 1998-02-02
GR3025809T3 (en) 1998-03-31
FI104068B1 (fi) 1999-11-15
CA2140344C (en) 1997-08-26
AU675654B2 (en) 1997-02-13
CA2140344A1 (en) 1994-02-03
WO1994002459A1 (en) 1994-02-03
CN1085894A (zh) 1994-04-27
ZA935304B (en) 1995-01-23
MX9304441A (es) 1994-07-29
JPH0641068A (ja) 1994-02-15
DE69315841D1 (de) 1998-01-29
EP0651743B1 (en) 1997-12-17
IL106359A0 (en) 1993-11-15
DE69315841T2 (de) 1998-04-09
AU4529193A (en) 1994-02-14
TW227556B (es) 1994-08-01
CZ15995A3 (en) 1995-09-13
JP2661841B2 (ja) 1997-10-08
FI933307A0 (fi) 1993-07-22
SK8695A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
NO20015448D0 (no) Kinolinderivater som inhibitorer av MEK enzymer
NO20015446L (no) Kinolin-derivater som inhibitorer for MEK-enzymer
HUT62264A (en) Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient
ES2110101T3 (es) Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa.
ATE113942T1 (de) Lipoxygenase inhibierende hydroxamsäure und n- hydroxyharnstoff-derivate.
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
DE69207597D1 (de) Lipoxygenase inhibierende tetrahydrobenzazepinderivate
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
DK0588850T3 (da) N-hydroxyureaderivater, som inhiberer lipoxygenase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 651743

Country of ref document: ES